Patient-care continuity
Clinical system resilience
Medical device security
Research and intellectual property protection
Pharmaceutical supply-chain assurance
A CONNECTED RISK ENVIRONMENT
Patient care and product integrity depend on secure operations
Healthcare and pharmaceutical organisations share sensitive data, specialised technology and demanding regulatory responsibilities. Their operational pressures, however, are different. Security planning must reflect how care is delivered and how medicines and therapies are researched, produced and distributed.
Healthcare delivery
Hospitals and care providers rely on electronic health records, diagnostic platforms, connected devices, identity systems and third-party services. A security incident can quickly become a clinical and operational problem, particularly when staff lose access to the systems they need.
Priority areas
- ›Clinical system availability
- ›Patient and workforce identity
- ›Connected medical technology
- ›Secure exchange of health information
- ›Ransomware preparedness
- ›Third-party access
Pharmaceutical and life sciences
Research data, trial information, manufacturing systems and quality records move across complex internal and external ecosystems. Security must protect intellectual property and regulated processes while allowing scientific, production and commercial teams to work efficiently.
Priority areas
- ›Research and development data
- ›Clinical trial environments
- ›Laboratory systems
- ›Manufacturing and quality operations
- ›Intellectual property
- ›Partners, CROs and contract manufacturers
WHERE EXPOSURE DEVELOPS
Security must follow the work, not stop at the perimeter
Sensitive information and operational dependencies move between people, platforms, facilities and external organisations. An effective programme examines the complete working environment.
CARE CANNOT WAIT
Prepare for the moment a cyber incident affects clinical work
Incident plans often explain how to contain malware or notify stakeholders. Healthcare teams also need to know how clinical work will continue when identity services, records, imaging, communications or connected equipment become unavailable.
“Recovery order should reflect clinical consequence, not technical convenience.”
Clinical dependency mapping
Identify the systems, interfaces and third parties that support essential care pathways.
Downtime readiness
Define practical procedures for working safely when digital services are unavailable.
Recovery prioritisation
Set restoration decisions around clinical impact, data integrity and operational dependency.
Exercise and improvement
Test decisions with clinical, technical, legal, communications and executive stakeholders.
FROM DISCOVERY TO DELIVERY
Protect the pharmaceutical lifecycle without obstructing progress
Research and discovery
Exposure
Valuable scientific information, collaboration platforms, laboratory data and proprietary methods.
Security focus
Identity controls, secure collaboration, research environment segmentation and intellectual property protection.
Clinical development
Exposure
Participant information, trial systems, international data exchange and third-party research partners.
Security focus
Access governance, data protection, supplier assurance, logging and incident accountability.
Manufacturing and quality
Exposure
Production technology, quality records, validated systems and specialised vendors.
Security focus
Segmentation, controlled change, resilient access, vulnerability management and recovery planning.
Distribution and commercial operations
Exposure
Logistics providers, product information, business systems and market-facing platforms.
Security focus
Third-party oversight, fraud prevention, application security, monitoring and continuity.
PRIORITY EXPOSURES
Risks that demand sector-specific attention
Ransomware and operational disruption
Attacks can interrupt access to clinical records, laboratory services, production systems and supporting infrastructure.
Compromised identities
Privileged, clinical, research and third-party accounts can provide broad access across connected environments.
Legacy and specialised technology
Older clinical equipment, laboratory platforms and production systems may be difficult to patch or replace.
Third-party dependency
A vendor incident can affect services, data or operations even when internal systems remain secure.
Research and intellectual property theft
Scientific work, trial results, formulations and product plans can have long-term strategic value to attackers.
Data integrity failure
Unauthorised or untraceable changes can undermine clinical decisions, research confidence and quality processes.
CONNECTED CLINICAL TECHNOLOGY
Treat device cybersecurity as a patient-safety and lifecycle responsibility
Connected devices introduce dependencies between manufacturers, healthcare providers, software components and supporting networks. The right approach considers design, deployment, maintenance, vulnerability handling and retirement rather than treating the device as an isolated endpoint.
Digisecuritas helps organisations examine device exposure, supporting infrastructure, third-party access and the operational process used to respond when vulnerabilities are discovered.
Discuss Medical Device Security →FDA guidance addresses cybersecurity across medical-device design, documentation and lifecycle risk, making this a legitimate operating concern rather than a decorative page theme. FDA medical-device cybersecurity guidance
PRACTICAL SECURITY SUPPORT
Services shaped around clinical, scientific and operational priorities
Cybersecurity risk assessment
Build a clear view of exposure across enterprise technology, clinical environments, laboratories, connected devices, manufacturing systems and external dependencies.
Included outcomes
- ›Prioritised risk register
- ›Control-gap analysis
- ›Critical dependency map
- ›Executive risk summary
- ›Practical improvement roadmap
Security architecture review
Review trust boundaries, identity flows, integrations, segmentation and critical service dependencies.
Penetration testing
Assess approved applications, infrastructure and APIs using a controlled scope and agreed safety constraints.
Cloud security assessment
Review configuration, identity, data protection, logging and resilience across cloud-hosted healthcare and research environments.
Third-party risk management
Evaluate vendors according to the data, access and operational dependency they introduce.
Incident response readiness
Develop and exercise response plans involving clinical, scientific, operational and executive stakeholders.
Virtual CISO and advisory
Provide experienced security leadership for governance, investment decisions and programme development.
Data privacy support
Connect security controls with the way sensitive health, trial and workforce information is collected and used.
Compliance readiness
Assess controls against relevant frameworks without presenting certification as the sole security objective.
Security testing must respect the environment it is intended to protect
DEPENDENCY RISK
Your security posture includes organisations you do not directly control
Cloud and software providers
Medical device vendors
CROs and research partners
Laboratories and universities
Your organisation
Manufacturers and logistics providers
Managed service providers
A supplier review should go beyond collecting questionnaires. Digisecuritas helps determine what a provider can access, what operations depend on it, how incidents are communicated and what evidence supports its control claims.
Assess Third-Party ExposurePREPARE BEFORE THE PRESSURE ARRIVES
Make response decisions before systems become unavailable
CISA maintains healthcare-specific ransomware and resilience resources, reinforcing the need for sector-aware preparation. CISA Healthcare and Public Health cybersecurity resources
Before an incident
- ›Identify critical services
- ›Confirm response authority
- ›Test backup integrity
- ›Document external contacts
- ›Prepare clinical and operational workarounds
During an incident
- ›Establish verified communications
- ›Determine operational impact
- ›Preserve evidence
- ›Contain affected access
- ›Coordinate technical and business decisions
During recovery
- ›Validate systems and data
- ›Restore by operational priority
- ›Monitor for renewed activity
- ›Communicate through approved channels
- ›Record lessons and control improvements
ASSURANCE WITH CONTEXT
Connect cybersecurity controls with the obligations that shape your organisation
Requirements vary by jurisdiction, business model, data use and product category. Digisecuritas helps teams map relevant obligations to operating controls, evidence and accountable owners. The objective is a defensible security programme rather than a collection of disconnected compliance tasks.
Requirements must be confirmed for the organisation's jurisdiction, processing activities and regulated products. Digisecuritas provides cybersecurity and compliance-readiness support, not legal advice.
NIST CSF 2.0 can support governance and risk management across organisations and sectors without prescribing one implementation method. NIST Cybersecurity Framework 2.0
Cybersecurity support across healthcare and life sciences
Hospitals and healthcare networks
Clinics and diagnostic providers
Pharmaceutical companies
Biotechnology organisations
Medical device manufacturers
Clinical research organisations
Laboratories and research centres
Digital health and health technology providers
A CLEAR PATH FORWARD
From initial context to measurable improvement
Security advice should remain useful after the assessment ends
Digisecuritas provides independent cybersecurity expertise without forcing organisations into a fixed technology stack. Our work is designed to give technical teams, risk owners and executives a shared understanding of what matters and what should happen next.
Independent perspective
Recommendations are based on exposure and business need.
Operational awareness
Findings are considered in the context of patient care, research and production.
Clear communication
Technical evidence is translated into decisions stakeholders can act on.
Practical priorities
Roadmaps reflect risk, dependency, effort and available resources.
FREQUENTLY ASKED QUESTIONS
Healthcare and pharmaceutical cybersecurity questions
Common questions about cybersecurity for hospitals, pharmaceutical companies, medical device manufacturers, clinical research organisations and digital health providers.
START WITH THE OPERATIONS THAT MATTER MOST
Strengthen security without losing sight of care, research or production
Tell us where your organisation is exposed, what cannot be interrupted and which decisions need greater confidence. We will help you define a focused first step.
For hospitals, healthcare providers, pharmaceutical companies, biotechnology organisations, laboratories and connected health businesses.